Featured Research

from universities, journals, and other organizations

Synthetic Peptide That Enhances The Effect Of A Bone Growth Factor

Date:

November 17, 2004

Source:

Brookhaven National Laboratory

Summary:

Researchers from the U.S. Department of Energy’s Brookhaven National Laboratory (BNL) and BioSurface Engineering Technologies, Inc. (BioSET) have developed a synthetic peptide that enhances the effects of a tissue growth factor known as bone morphogenetic protein 2, or BMP-2. BMPs are a family of proteins in the human body responsible for the proliferation, repair, and differentiation of cells in many tissues, including bone.

UPTON, NY – Researchers from the U.S. Department of Energy’s Brookhaven National Laboratory (BNL) and BioSurface Engineering Technologies, Inc. (BioSET) have developed a synthetic peptide that enhances the effects of a tissue growth factor known as bone morphogenetic protein 2, or BMP-2. BMPs are a family of proteins in the human body responsible for the proliferation, repair, and differentiation of cells in many tissues, including bone.

Related Articles

The researchers designed one portion of the peptide to target the BMP-2 receptor molecules that occur on the surface of bone-forming stem cells and another portion to interact with BioSET’s drug-binding agent HepaSil™, a heparin-based product. The peptide, called B2A2, is one of a series of synthetic analogs of naturally occurring growth factors being developed in the Brookhaven/BioSET collaboration.

This research is reported in the November 8th online version of the Journal of Bone & Mineral Research.

“Our study shows that a small amount of the peptide that we developed increases the effectiveness of BMP-2 as much as 40 times,” said Brookhaven scientist Louis Peña, senior author of the paper. “This peptide unlocks a synergy with BMP-2. In a cell culture model, we used BMP at doses too low to have any observable effect by itself, and the same was true for the B2A2 peptide. But when the two were added together in the same low doses, the cells were strongly triggered to develop into bone-forming cells.

“First-generation BMP-impregnated medical devices are currently used clinically for spine repair and to accelerate the healing of long bones,” Peña continued. “These devices show effectiveness in inducing bone repair, but there is concern over the high levels of the growth factors that are currently required. An agent that decreases the amount of BMP needed or one that can recruit the body’s own growth factors to be more effective could have a substantial clinical benefit.”

The growth factor analogs developed in the Brookhaven/BioSET collaboration are synthetic peptides that are chemically more stable and easier to produce than natural growth factors or growth factors derived by recombinant protein techniques. BioSET has an exclusive license to develop and market these bioactive analogs.

Thomas Roueché, BioSET’s president, said, “We are fortunate to enjoy a fruitful collaboration. This class of peptide and others under development supports the concept of design-targeted synthetic peptides for specific tissue regeneration applications. The Brookhaven/BioSET collaboration continues to yield very promising results aimed at replicating human growth factors, and we look forward to further validating the potential of these peptides to enhance the body’s healing capacity, especially when combined with orthopedic implants.”

He added, “We believe the future of orthopedics will continue evolving towards combination products, such as devices that have been biologically enhanced. For example, approved growth factor-type combination device products are currently valued at over $1.6 billion. Our ability to bring new bioactive peptides into the mix of new product development positions us at the leading edge of an important evolution in orthopedic medicine.”

This research was funded by the National Institutes of Health and BioSET.About BioSET

BioSurface Engineering Technologies, Inc., is a private, development stage company dedicated to bringing therapeutic combinations to medical devices to improve performance and patient well being. BioSET’s synthetic peptides for tissue regeneration either separately or in combination with the HepaSil™ drug delivery linker technology continue to show promising results in pre-clinical studies for enhancing tissue repair in the fields of vascular, orthopedic and chronic wound diseases. The company is positioned to capitalize on the convergence of drugs/biologics with medical devices as combination products and seeks to offer their novel peptides and methods of delivery to surgical implant industry partners. For more information, visit BioSET’s website at: http://www.biosetinc.com.

Brookhaven National Laboratory. "Synthetic Peptide That Enhances The Effect Of A Bone Growth Factor." ScienceDaily. ScienceDaily, 17 November 2004. <www.sciencedaily.com/releases/2004/11/041116220505.htm>.

Brookhaven National Laboratory. (2004, November 17). Synthetic Peptide That Enhances The Effect Of A Bone Growth Factor. ScienceDaily. Retrieved March 3, 2015 from www.sciencedaily.com/releases/2004/11/041116220505.htm

Brookhaven National Laboratory. "Synthetic Peptide That Enhances The Effect Of A Bone Growth Factor." ScienceDaily. www.sciencedaily.com/releases/2004/11/041116220505.htm (accessed March 3, 2015).

More From ScienceDaily

More Health & Medicine News

Featured Research

Mar. 3, 2015 — Adults over the age of 30 only catch flu about twice a decade, a new study suggests. So, while it may feel like more, flu-like illness can be caused by many pathogens, making it difficult to assess ... full story

Mar. 3, 2015 — No significant change in home habits of smokers have been observed in the aftermath of a ban on smoking in public spaces, researchers report. Greater inspiration to kick the habit likely comes from ... full story

Mar. 3, 2015 — Heart function has been associated with the development of dementia and Alzheimer's disease through a new study. Participants with decreased heart function, measured by cardiac index, were two to ... full story

Mar. 3, 2015 — Children of recently separated or divorced families are likelier to drink sugar-sweetened beverages than children in families where the parents are married, putting them at higher risk for obesity ... full story

Mar. 3, 2015 — Gastric bypass and similar stomach-shrinking surgeries are a popular option for obese patients looking to lose weight or treat type 2 diabetes. While the surgeries have been linked to a decreased ... full story

Mar. 3, 2015 — Most people consume more salt than they need and therefore have a higher risk of heart disease and stroke, which are the two leading causes of death worldwide. But a new study reveals that dietary ... full story

Mar. 3, 2015 — Twice as many children born to mothers who took antibiotics during pregnancy were diagnosed with asthma by age 3 than children born to mothers who didn’t take prenatal antibiotics, a new study has ... full story

Mar. 3, 2015 — Pediatric otolaryngologists and surgeons are concerned with parents getting the wrong message regarding the safety/desirability of letting babies and young children eat peanuts to prevent them from ... full story

Featured Videos

Mom Triumphs Over Tragedy, Helps Other Families

AP (Mar. 3, 2015) — After her son, Dax, died from a rare form of leukemia, Julie Locke decided to give back to the doctors at St. Jude Children&apos;s Research Hospital who tried to save his life. She raised $1.6M to help other patients and their families. (March 3)
Video provided by AP

Looted and Leaking, South Sudan's Oil Wells Pose Health Risk

AFP (Mar. 3, 2015) — Thick black puddles and a looted, leaking ruin are all that remain of the Thar Jath oil treatment facility, once a crucial part of South Sudan&apos;s mainstay industry. Duration: 01:13
Video provided by AFP

Woman Convicted of Poisoning Son

AP (Mar. 3, 2015) — A woman who blogged for years about her son&apos;s constant health woes was convicted Monday of poisoning him to death by force-feeding heavy concentrations of sodium through his stomach tube. (March 3)
Video provided by AP

Related Stories

Aug. 19, 2014 — Chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or defects, this coated ... full story

July 2, 2014 — Patients suffering from osteoporosis or bone fractures might benefit from a new discovery of a protein that plays an important role in bone regeneration made by bioengineers. Normally found in the ... full story

May 29, 2014 — Traumatic bone injuries such as blast wounds are often so severe that the body can't effectively repair the damage on its own. To aid the recovery, clinicians inject patients with proteins ... full story

Feb. 20, 2013 — Following accidents or cancer surgery surgeons often have to transplant healthy bone tissue or synthetic material to repair the resulting bone defects. Unfortunately, these procedures do not always ... full story

Aug. 2, 2010 — Scientists have developed a material for bone grafts that could one day replace the 'gold standard' natural bone implants. A new study shows how particles of a ceramic called calcium ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.